Notes / Company

Astrazeneca Pharma India Ltd.

ASTRAZEN BSE 506820 ISIN INE203A01020 Pharmaceuticals

Fundamentals

Market cap: ₹21,468 cr
P/E: 106.87×
ROE: 15.02%
Debt / equity: 0.00
Div yield: 0.37%
52-week range: 7551.50 — 10691.00

Research on Tijori Finance

The timeline — 1 note on Astrazeneca Pharma India Ltd.

May 2026

21 May 26 · 13:27 IST Lead

Lead

AstraZeneca India wins CDSCO nod for Calquence in MCL

Second Indian approval for BTK inhibitor after CLL; broadens addressable patient pool in aggressive lymphoma.

Verify on exchange BSE filings for ASTRAZEN NSE filings for ASTRAZEN Tijori Finance company page